ARTICLE | Company News
Argyll Biotechnologies LLC, Immunosyn deal
October 29, 2007 7:00 AM UTC
The companies expanded IMYN's rights under a September 2006 deal to include all indications for Argyll's SF-1019. IMYN previously had rights to the group of low molecular weight lipopeptides for medi...